Literature DB >> 6773181

Some properties of antithrombin-III and its concentration in human plasma.

G Murano, L Williams, M Miller-Andersson, D L Aronson, C King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6773181     DOI： 10.1016/0049-3848(80)90190-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

Review 2.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

3.  Flow-simulated thrombin generation profiles as a predictor of thrombotic risk among pre-menopausal women.

Authors:  Sumanas W Jordan; Matthew A Corriere; Carla Y Vossen; Frits R Rosendaal; Elliot L Chaikof
Journal:  Thromb Haemost       Date:  2012-06-12       Impact factor: 5.249

4.  Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.

Authors:  Hai Yang; Qing-Wang Li; Zeng-Sheng Han; Jian-Hong Hu; Wen-Ye Li; Zhi-Bin Liu
Journal:  J Thromb Thrombolysis       Date:  2009-05-20       Impact factor: 2.300

5.  In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.

Authors:  Junko Ichikawa; Satoshi Hagihira; Testu Mori; Mitsuharu Kodaka; Keiko Nishiyama; Makoto Ozaki; Makiko Komori
Journal:  J Anesth       Date:  2016-08-08       Impact factor: 2.078

6.  Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.

Authors:  R B Simmons; G R Newton; V M Doctor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

7.  Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.

Authors:  C F Scott; R W Carrell; C B Glaser; F Kueppers; J H Lewis; R W Colman
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides.

Authors:  T W Barrowcliffe; S J Havercroft; G Kemball-Cook; U Lindahl
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

9.  Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors.

Authors:  Takumi Tsuchida; Mineji Hayakawa; Shota Kawahara; Osamu Kumano
Journal:  Thromb J       Date:  2022-05-18

10.  A novel variation of SERPINC1 caused deep venous thrombosis in a Chinese family: A case report.

Authors:  Yu Peng; Tun Wang; Yu Zheng; Aojie Lian; Di Zhang; Zhimin Xiong; Zhengmao Hu; Kun Xia; Chang Shu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.